ArticleClinical pharmacokinetics2013

Single-center evaluation of the single-dose pharmacokinetics of the angiotensin II receptor antagonist azilsartan medoxomil in renal impairment.

Richard A Preston et al.PubMed ↗Publisher ↗

No numbers read from the abstract.